| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.4 | 0.009 |